FindMyKOL
Clinical trialNCT01948180TerminatedPhase 2Interventional

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma

SponsorCell Medica LtdEnrollment15EBVLymphoma, Extranodal NK-T-Cell
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive EBV positive extranodal NK/T-cell lymphoma
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Universitaire Ouest

    Paris, France

  • Centre Hospitalier de Lyon

    Pierre-Bénite, France

South Korea
  • Asan Cancer Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

United Kingdom
  • University College London Hospital

    London, UK, United Kingdom

  • the Christie Clinic

    Manchester, UK, United Kingdom

United States
  • Dana-Farber Cancer Center

    Boston, Massachusetts, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • the Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Baltaleucel-T
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2014
Primary completion
16 Apr 2018
Completion
7 Sept 2018
Last update posted
13 Mar 2019
Registered enrollment
15
Registry id
NCT01948180
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.